Nascent Biotech Inc (NBIO)
0.0899
+0.01
(+8.57%)
USD |
OTCM |
Jun 21, 16:00
Nascent Biotech Shareholders Equity (Quarterly): 0.0304M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0304M |
| September 30, 2023 | -0.0064M |
| June 30, 2023 | -1.155M |
| March 31, 2023 | -1.296M |
| December 31, 2022 | -1.364M |
| September 30, 2022 | -1.188M |
| June 30, 2022 | -1.437M |
| March 31, 2022 | -0.6715M |
| December 31, 2021 | -0.448M |
| September 30, 2021 | -1.045M |
| June 30, 2021 | -0.8343M |
| March 31, 2021 | -0.4725M |
| December 31, 2020 | -1.232M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.811M |
| June 30, 2020 | -1.397M |
| March 31, 2020 | -2.876M |
| December 31, 2019 | -0.9525M |
| September 30, 2019 | -0.8011M |
| June 30, 2019 | -0.6206M |
| March 31, 2019 | -0.4822M |
| December 31, 2018 | -0.4913M |
| September 30, 2018 | -0.3906M |
| June 30, 2018 | -10.72M |
| March 31, 2018 | -0.0864M |
| December 31, 2017 | 0.6467M |
| March 31, 2017 | 0.7338M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.876M
Minimum
Mar 2020
0.0304M
Maximum
Dec 2023
-0.9778M
Average
-0.9525M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 24.86M |
| Theriva Biologics Inc | 34.12M |
| Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.6413M |
| Total Liabilities (Quarterly) | 0.6109M |